An evaluation of Haemophilus influenzae type b (Hib) vaccination and description of Risk factors for Hib vaccine failure in Europe 1996-1998
During the past decade, conjugate vaccines against Haemophilus influenzae type b (Hib) infection have been introduced for routine use in infants into several countries in Europe. Currently, the vaccination programmes in these countries differ with respect to the choice of vaccine, the schedule for primary immunisation, and the use of a booster dose in the second year of life.
Influenza virus characterisation, December 2019
16 Jan 2020 - This is the third report for the 2019–20 influenza season. As of week 1/2020, 42 844 influenza detections had been reported across the WHO European Region; 85% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 15% type B viruses, with 531 (92%) of 576 ascribed to a B/Victoria lineage.
Monthly measles and rubella monitoring report, January 2020
10 Jan 2020 - The monitoring report is based on measles and rubella data from The European Surveillance System (TESSy) for the period 1 December 2018 to 30 November 2019.